Clinical & Experimental Immunology
@ceijournal.bsky.social
The journal of #translational #immunology 🔃
British Society for Immunology journal publishing high-quality & impactful research since 1966
British Society for Immunology journal publishing high-quality & impactful research since 1966
📢 We’re welcoming high‑quality translational immunology submissions! If your research offers novel mechanistic insight into human disease, we want to hear from you.
Submit your work: https://bit.ly/3LjuI2A
Submit your work: https://bit.ly/3LjuI2A
January 31, 2026 at 10:19 AM
📢 We’re welcoming high‑quality translational immunology submissions! If your research offers novel mechanistic insight into human disease, we want to hear from you.
Submit your work: https://bit.ly/3LjuI2A
Submit your work: https://bit.ly/3LjuI2A
🔬 Jan Devan et al. identify distinct pro‑inflammatory T‑cell populations in Crohn’s disease lesions, including CD4⁺CD39⁺ TCRαβ⁺ cells and activated TCR Vδ1⁺ cells, highlighting potential new therapeutic targets.
Read the article: https://bit.ly/3LitpGu
#CrohnsDisease
Read the article: https://bit.ly/3LitpGu
#CrohnsDisease
January 30, 2026 at 5:29 PM
🔬 Jan Devan et al. identify distinct pro‑inflammatory T‑cell populations in Crohn’s disease lesions, including CD4⁺CD39⁺ TCRαβ⁺ cells and activated TCR Vδ1⁺ cells, highlighting potential new therapeutic targets.
Read the article: https://bit.ly/3LitpGu
#CrohnsDisease
Read the article: https://bit.ly/3LitpGu
#CrohnsDisease
📘 See CEI’s top-performing papers of 2025!
Explore our 2025 must‑read articles, highlighting impactful immunology research
Read more: https://bit.ly/45ELeXc
Explore our 2025 must‑read articles, highlighting impactful immunology research
Read more: https://bit.ly/45ELeXc
January 29, 2026 at 2:35 PM
📘 See CEI’s top-performing papers of 2025!
Explore our 2025 must‑read articles, highlighting impactful immunology research
Read more: https://bit.ly/45ELeXc
Explore our 2025 must‑read articles, highlighting impactful immunology research
Read more: https://bit.ly/45ELeXc
MOG/NMDAR overlapping syndrome is increasingly recognised.
This review shows common symptoms (psychiatric changes, seizures), typical MRI patterns, good treatment response, but a notably higher recurrence rate.
Read here📄 https://bit.ly/3Q2S29A
This review shows common symptoms (psychiatric changes, seizures), typical MRI patterns, good treatment response, but a notably higher recurrence rate.
Read here📄 https://bit.ly/3Q2S29A
January 15, 2026 at 2:46 PM
MOG/NMDAR overlapping syndrome is increasingly recognised.
This review shows common symptoms (psychiatric changes, seizures), typical MRI patterns, good treatment response, but a notably higher recurrence rate.
Read here📄 https://bit.ly/3Q2S29A
This review shows common symptoms (psychiatric changes, seizures), typical MRI patterns, good treatment response, but a notably higher recurrence rate.
Read here📄 https://bit.ly/3Q2S29A
Crohn’s disease lesions show enrichment of CD4⁺CD39⁺ TCRαβ⁺ TEM cells producing IL‑17/IL‑21 and terminally differentiated TCR Vδ1⁺ cells producing TNF‑α/IFN‑γ.
Distinct inflammatory roles point to Vδ1⁺ cells as a potential therapeutic target.
📄 https://bit.ly/3LitpGu
Distinct inflammatory roles point to Vδ1⁺ cells as a potential therapeutic target.
📄 https://bit.ly/3LitpGu
January 14, 2026 at 10:50 AM
Crohn’s disease lesions show enrichment of CD4⁺CD39⁺ TCRαβ⁺ TEM cells producing IL‑17/IL‑21 and terminally differentiated TCR Vδ1⁺ cells producing TNF‑α/IFN‑γ.
Distinct inflammatory roles point to Vδ1⁺ cells as a potential therapeutic target.
📄 https://bit.ly/3LitpGu
Distinct inflammatory roles point to Vδ1⁺ cells as a potential therapeutic target.
📄 https://bit.ly/3LitpGu
Despite elevated KLR and mitochondrial gene expression, Tregs in autoimmune PAI show normal frequency and suppressive function, suggesting limited involvement in disease pathogenesis.
📄 https://bit.ly/3Q2QVGU
📄 https://bit.ly/3Q2QVGU
January 12, 2026 at 11:00 AM
Despite elevated KLR and mitochondrial gene expression, Tregs in autoimmune PAI show normal frequency and suppressive function, suggesting limited involvement in disease pathogenesis.
📄 https://bit.ly/3Q2QVGU
📄 https://bit.ly/3Q2QVGU
Working in immunology?
Clinical & Experimental Immunology publishes impactful studies across six core sections plus areas like immunometabolism, mucosal immunity, and immunotherapy.
Learn more about submitting your next manuscript to CEI: https://bit.ly/443pf8s
Clinical & Experimental Immunology publishes impactful studies across six core sections plus areas like immunometabolism, mucosal immunity, and immunotherapy.
Learn more about submitting your next manuscript to CEI: https://bit.ly/443pf8s
January 9, 2026 at 10:15 AM
Working in immunology?
Clinical & Experimental Immunology publishes impactful studies across six core sections plus areas like immunometabolism, mucosal immunity, and immunotherapy.
Learn more about submitting your next manuscript to CEI: https://bit.ly/443pf8s
Clinical & Experimental Immunology publishes impactful studies across six core sections plus areas like immunometabolism, mucosal immunity, and immunotherapy.
Learn more about submitting your next manuscript to CEI: https://bit.ly/443pf8s
Important CIDP research shows significant changes in circulating B‑cell subsets and elevated IL10/TNFA expression, correlating with disability scores and nerve fiber density. Valuable insights for understanding disease activity.
📄 https://bit.ly/3rzemhN
📄 https://bit.ly/3rzemhN
January 8, 2026 at 11:50 AM
Important CIDP research shows significant changes in circulating B‑cell subsets and elevated IL10/TNFA expression, correlating with disability scores and nerve fiber density. Valuable insights for understanding disease activity.
📄 https://bit.ly/3rzemhN
📄 https://bit.ly/3rzemhN
This study highlights 2B4 (CD244) as a key receptor driving Staphylococcus aureus–associated allergic inflammation. SEB binds and activates 2B4, amplifying eosinophil responses, pointing to a promising therapeutic target.
📄 https://bit.ly/4my2B1e
📄 https://bit.ly/4my2B1e
January 7, 2026 at 2:03 PM
This study highlights 2B4 (CD244) as a key receptor driving Staphylococcus aureus–associated allergic inflammation. SEB binds and activates 2B4, amplifying eosinophil responses, pointing to a promising therapeutic target.
📄 https://bit.ly/4my2B1e
📄 https://bit.ly/4my2B1e
Happy holidays from all of us! ❄️✨
Thank you to our authors, reviewers, and readers for another great year. We look forward to welcoming your submissions in the new year!
Thank you to our authors, reviewers, and readers for another great year. We look forward to welcoming your submissions in the new year!
December 24, 2025 at 1:09 PM
Happy holidays from all of us! ❄️✨
Thank you to our authors, reviewers, and readers for another great year. We look forward to welcoming your submissions in the new year!
Thank you to our authors, reviewers, and readers for another great year. We look forward to welcoming your submissions in the new year!
🎧 CEI Wrapped!
A standout year for Clinical & Experimental Immunology!
Thank you to our authors, reviewers and readers for helping CEI grow its reach and impact in 2025.
A standout year for Clinical & Experimental Immunology!
Thank you to our authors, reviewers and readers for helping CEI grow its reach and impact in 2025.
December 10, 2025 at 5:40 PM
🎧 CEI Wrapped!
A standout year for Clinical & Experimental Immunology!
Thank you to our authors, reviewers and readers for helping CEI grow its reach and impact in 2025.
A standout year for Clinical & Experimental Immunology!
Thank you to our authors, reviewers and readers for helping CEI grow its reach and impact in 2025.
Well done to the recipients of this year’s BSI journals-sponsored Poster Prizes! 🎉
Congrats to Flavio Beke, Aisling Newing & Rébecca Barascud for their brilliant contributions. 👏
Read more: https://bit.ly/3MljD6r
Congrats to Flavio Beke, Aisling Newing & Rébecca Barascud for their brilliant contributions. 👏
Read more: https://bit.ly/3MljD6r
December 5, 2025 at 3:49 PM
Well done to the recipients of this year’s BSI journals-sponsored Poster Prizes! 🎉
Congrats to Flavio Beke, Aisling Newing & Rébecca Barascud for their brilliant contributions. 👏
Read more: https://bit.ly/3MljD6r
Congrats to Flavio Beke, Aisling Newing & Rébecca Barascud for their brilliant contributions. 👏
Read more: https://bit.ly/3MljD6r
Attending #BSI25? Don't miss 'Immunology in the Balance' at 16:30 today. 🧬⚖️
See our very own Editor-in-chief Claudia Mauri discuss how immunity is regulated to stay effective & safe.
See the programme here: https://bit.ly/4a5iBp1
See our very own Editor-in-chief Claudia Mauri discuss how immunity is regulated to stay effective & safe.
See the programme here: https://bit.ly/4a5iBp1
December 3, 2025 at 1:00 PM
Attending #BSI25? Don't miss 'Immunology in the Balance' at 16:30 today. 🧬⚖️
See our very own Editor-in-chief Claudia Mauri discuss how immunity is regulated to stay effective & safe.
See the programme here: https://bit.ly/4a5iBp1
See our very own Editor-in-chief Claudia Mauri discuss how immunity is regulated to stay effective & safe.
See the programme here: https://bit.ly/4a5iBp1
Attending #BSI25?📣 Don’t miss AI in Publishing with Rachel Moriarty from our publisher OUP.
Explore how AI is shaping journals, research integrity & ethical practice, plus tips for using AI responsibly as an author.
🗓 3 Dec 2025 | ⏰ 13:15–14:10 | 📍 Hall 1C
Explore how AI is shaping journals, research integrity & ethical practice, plus tips for using AI responsibly as an author.
🗓 3 Dec 2025 | ⏰ 13:15–14:10 | 📍 Hall 1C
December 3, 2025 at 11:34 AM
Attending #BSI25?📣 Don’t miss AI in Publishing with Rachel Moriarty from our publisher OUP.
Explore how AI is shaping journals, research integrity & ethical practice, plus tips for using AI responsibly as an author.
🗓 3 Dec 2025 | ⏰ 13:15–14:10 | 📍 Hall 1C
Explore how AI is shaping journals, research integrity & ethical practice, plus tips for using AI responsibly as an author.
🗓 3 Dec 2025 | ⏰ 13:15–14:10 | 📍 Hall 1C
Attending #BSI25? 📣 Meet our Editor-in-Chief, Claudia Mauri!
Join us at the BSI stand this evening (18:00–19:30) in the exhibition hall to hear more about Immunology and Clinical & Experimental Immunology. Come say hello! 👋
Join us at the BSI stand this evening (18:00–19:30) in the exhibition hall to hear more about Immunology and Clinical & Experimental Immunology. Come say hello! 👋
December 2, 2025 at 11:12 AM
Attending #BSI25? 📣 Meet our Editor-in-Chief, Claudia Mauri!
Join us at the BSI stand this evening (18:00–19:30) in the exhibition hall to hear more about Immunology and Clinical & Experimental Immunology. Come say hello! 👋
Join us at the BSI stand this evening (18:00–19:30) in the exhibition hall to hear more about Immunology and Clinical & Experimental Immunology. Come say hello! 👋
🔬 New in the “Clinical & Experimental Treatment of…” series: residual immune activation persists in people with HIV on ART. This review explores strategies to reduce inflammation and guide future research.
📖 https://bit.ly/4g5VMm4
##HIV #Immunology #ART #WorldAIDSday
📖 https://bit.ly/4g5VMm4
##HIV #Immunology #ART #WorldAIDSday
December 1, 2025 at 12:05 PM
🔬 New in the “Clinical & Experimental Treatment of…” series: residual immune activation persists in people with HIV on ART. This review explores strategies to reduce inflammation and guide future research.
📖 https://bit.ly/4g5VMm4
##HIV #Immunology #ART #WorldAIDSday
📖 https://bit.ly/4g5VMm4
##HIV #Immunology #ART #WorldAIDSday
Rotavirus vaccines save lives, but CMV exposure may reduce responses in some infants. New research highlights this challenge in HIV-exposed, uninfected babies, underscoring the need for equity in early-life health.
📖 Learn more: https://bit.ly/3DX1oAq
##WorldAIDSDay #Immunology #ChildHealth
📖 Learn more: https://bit.ly/3DX1oAq
##WorldAIDSDay #Immunology #ChildHealth
December 1, 2025 at 10:52 AM
Rotavirus vaccines save lives, but CMV exposure may reduce responses in some infants. New research highlights this challenge in HIV-exposed, uninfected babies, underscoring the need for equity in early-life health.
📖 Learn more: https://bit.ly/3DX1oAq
##WorldAIDSDay #Immunology #ChildHealth
📖 Learn more: https://bit.ly/3DX1oAq
##WorldAIDSDay #Immunology #ChildHealth
🦠 How do gut cells shape infections? This study, part of the Review Series - Organoids to Study Immune Cells Development and Function (Ed. Joana Neves), uses organoids to reveal how pathogens target specific cells!
🔬 Read more: https://bit.ly/422Z96U
#GutHealth #Organoids #InfectiousDiseases
🔬 Read more: https://bit.ly/422Z96U
#GutHealth #Organoids #InfectiousDiseases
November 27, 2025 at 4:50 PM
🦠 How do gut cells shape infections? This study, part of the Review Series - Organoids to Study Immune Cells Development and Function (Ed. Joana Neves), uses organoids to reveal how pathogens target specific cells!
🔬 Read more: https://bit.ly/422Z96U
#GutHealth #Organoids #InfectiousDiseases
🔬 Read more: https://bit.ly/422Z96U
#GutHealth #Organoids #InfectiousDiseases
🛡️ This #PublishingIntegrityWeek, BSI journals are tackling papermills, promoting AI transparency, DEI & accessibility, and supporting ethical research in immunology.
Read more 👉 https://bit.ly/4odyvAZ
Read more 👉 https://bit.ly/4odyvAZ
November 21, 2025 at 5:05 PM
🛡️ This #PublishingIntegrityWeek, BSI journals are tackling papermills, promoting AI transparency, DEI & accessibility, and supporting ethical research in immunology.
Read more 👉 https://bit.ly/4odyvAZ
Read more 👉 https://bit.ly/4odyvAZ
💙 On #WorldDiabetesDay, explore new insights into immune regulation in childhood #T1D.
An Open Access study in Clinical & Experimental Immunology links Galectin-1 with inflammation & Treg cells in children with type 1 diabetes.
Read more 👉 https://bit.ly/4r3C2Vw
An Open Access study in Clinical & Experimental Immunology links Galectin-1 with inflammation & Treg cells in children with type 1 diabetes.
Read more 👉 https://bit.ly/4r3C2Vw
November 14, 2025 at 10:41 AM
💙 On #WorldDiabetesDay, explore new insights into immune regulation in childhood #T1D.
An Open Access study in Clinical & Experimental Immunology links Galectin-1 with inflammation & Treg cells in children with type 1 diabetes.
Read more 👉 https://bit.ly/4r3C2Vw
An Open Access study in Clinical & Experimental Immunology links Galectin-1 with inflammation & Treg cells in children with type 1 diabetes.
Read more 👉 https://bit.ly/4r3C2Vw
Tomorrow marks #WorldDiabetesDay, check out this Open Access study: a new LIPS assay detects zinc transporter 8 autoantibodies (ZnT8A) quickly, safely, and with minimal blood, helping identify children at risk for type 1 diabetes.
Read more 👉 https://bit.ly/3JBSPhw
Read more 👉 https://bit.ly/3JBSPhw
November 13, 2025 at 6:56 PM
Tomorrow marks #WorldDiabetesDay, check out this Open Access study: a new LIPS assay detects zinc transporter 8 autoantibodies (ZnT8A) quickly, safely, and with minimal blood, helping identify children at risk for type 1 diabetes.
Read more 👉 https://bit.ly/3JBSPhw
Read more 👉 https://bit.ly/3JBSPhw
🧫 Organoids reveal how gut epithelial diversity shapes host–pathogen interactions, enabling study of viruses, bacteria & parasites previously impossible in vitro.
👉 https://bit.ly/422Z96U
##Organoids #GutImmunology #Immunology
👉 https://bit.ly/422Z96U
##Organoids #GutImmunology #Immunology
November 7, 2025 at 10:25 AM
🧫 Organoids reveal how gut epithelial diversity shapes host–pathogen interactions, enabling study of viruses, bacteria & parasites previously impossible in vitro.
👉 https://bit.ly/422Z96U
##Organoids #GutImmunology #Immunology
👉 https://bit.ly/422Z96U
##Organoids #GutImmunology #Immunology
📘 People living with HIV can experience residual immune activation even on ART, raising comorbidity risks.
Krystelle Nganou-Makamdop reviews human studies on anti-inflammatory therapies and future strategies.
👉 https://bit.ly/4g5VMm4
##HIV #Immunology
Krystelle Nganou-Makamdop reviews human studies on anti-inflammatory therapies and future strategies.
👉 https://bit.ly/4g5VMm4
##HIV #Immunology
November 6, 2025 at 1:00 PM
📘 People living with HIV can experience residual immune activation even on ART, raising comorbidity risks.
Krystelle Nganou-Makamdop reviews human studies on anti-inflammatory therapies and future strategies.
👉 https://bit.ly/4g5VMm4
##HIV #Immunology
Krystelle Nganou-Makamdop reviews human studies on anti-inflammatory therapies and future strategies.
👉 https://bit.ly/4g5VMm4
##HIV #Immunology
New study finds IL-17 deficiency may underlie cryptococcosis in HIV-negative “immunocompetent” adults. Could unlock new paths for immunotherapy! 🦠🧬
Open access: https://bit.ly/47rL1Xq
##Immunology #Cryptococcosis #IL17 #InfectiousDiseases
Open access: https://bit.ly/47rL1Xq
##Immunology #Cryptococcosis #IL17 #InfectiousDiseases
October 30, 2025 at 2:43 PM
New study finds IL-17 deficiency may underlie cryptococcosis in HIV-negative “immunocompetent” adults. Could unlock new paths for immunotherapy! 🦠🧬
Open access: https://bit.ly/47rL1Xq
##Immunology #Cryptococcosis #IL17 #InfectiousDiseases
Open access: https://bit.ly/47rL1Xq
##Immunology #Cryptococcosis #IL17 #InfectiousDiseases
Heading to #BSACI2025? 🫁
We’ve been looking at how allergens ramp up IL-18 & IL-18Rα in Th2/Th17 cells in allergic asthma, and what that means for therapy.
👉 https://bit.ly/4qgknJE
##Allergy #Immunology
We’ve been looking at how allergens ramp up IL-18 & IL-18Rα in Th2/Th17 cells in allergic asthma, and what that means for therapy.
👉 https://bit.ly/4qgknJE
##Allergy #Immunology
October 17, 2025 at 9:40 AM
Heading to #BSACI2025? 🫁
We’ve been looking at how allergens ramp up IL-18 & IL-18Rα in Th2/Th17 cells in allergic asthma, and what that means for therapy.
👉 https://bit.ly/4qgknJE
##Allergy #Immunology
We’ve been looking at how allergens ramp up IL-18 & IL-18Rα in Th2/Th17 cells in allergic asthma, and what that means for therapy.
👉 https://bit.ly/4qgknJE
##Allergy #Immunology